Find a Tender · Contract

Approved Dosimetry Services (ADS)

A public procurement published by CTM Portal for the NDA Shared Services Alliance via Find a Tender.

Find a TenderContract
Award value
£7.5m
Tender value
2
Suppliers
4
Awards
3
Notices
Contract
Stage

Overview

Approved Dosimetry Services (ADS)

Key details

Source
Find a Tender
Lifecycle stage
Contract
Status
active
CPV classification
71900000 — Laboratory services
Currency
GBP
Total award value
Tender value
£7,500,000
First published
20 Sept 2022
Last updated
11 Jul 2023
View the original notice

Awards

4 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Cavendish Nuclear03975999active
Cavendish Nuclear03975999active
Nuvia Limited02063786active
Cavendish Nuclear03975999active

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeApproved Dosimetry Services (ADS)
  2. Tender updateApproved Dosimetry Services (ADS)
  3. Award,contractApproved Dosimetry Services (ADS)

All suppliers

Frameworks & programmes

More from CTM Portal for the NDA Shared Services Alliance

FAQs about this procurement

Who is the buyer for "Approved Dosimetry Services (ADS)"?

Approved Dosimetry Services (ADS) is a UK public-sector procurement published by CTM Portal for the NDA Shared Services Alliance via Find a Tender.

Has "Approved Dosimetry Services (ADS)" been awarded?

Yes — 4 awards are recorded, with a reported total value of £7,500,000. The current lifecycle stage is "Contract".

Which suppliers are involved in "Approved Dosimetry Services (ADS)"?

2 suppliers are linked: Cavendish Nuclear, Nuvia Limited.

What is "Approved Dosimetry Services (ADS)" worth?

The reported tender value is £7,500,000.

When was "Approved Dosimetry Services (ADS)" published?

It was first published on 20 Sept 2022 and last updated on 11 Jul 2023, across 3 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable